MP Global: Global Landscape of GLP Tox Outsourcing – A booming frontier for CROs
It is our pleasure to share with you our Global Landscape of GLP Tox Outsourcing – A booming frontier for CROs. GLP Tox outsourcing market is expected to touch ~$13B by 2028, driven by expanding R&D pipeline, including the rise in complex therapies. Tox testing, especially GLP Tox, remains one of the most commonly outsourced activities by biopharma. To cater to the evolving needs of the biopharma industry, the CROs will need to expand to more specialized tox offerings, differentiated animal…